We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M Turnover 66.25%
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
-0.5%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$75.5M
AUM Growth
+$8.01M
Cap. Flow
-$2.58M
Cap. Flow %
-3.43%
Top 10 Hldgs %
33.84%
Holding
120
New
37
Increased
26
Reduced
20
Closed
30
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0.3 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.6 years
Top 10 Avg Time Held Equity only
0.3 years
Top 20 Avg Time Held Equity only
0.5 years

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$1.8M
2
CI icon
Cigna
CI
+$1.51M
3
ABBV icon
AbbVie
ABBV
+$1.05M
4
RRC icon
Range Resources
RRC
+$1.01M
5
UNH icon
UnitedHealth
UNH
+$973K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.74M
2
VYGR icon
Voyager Therapeutics
VYGR
+$1.64M
3
BAX icon
Baxter International
BAX
+$1.6M
4
META icon
Meta Platforms (Facebook)
META
+$1.25M
5
NOW icon
ServiceNow
NOW
+$1.19M

Sector Composition

Rank Sector Weight
1 Healthcare 48.68%
2 Miscellaneous 22.7%
3 Energy 5.97%
4 Technology 5.96%
5 Communication Services 5.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
XLV icon
1
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$46.2B
$3.94M 5.22%
+57,200
New +$3.97M
2016 Q4
0 quarters
BIIB icon
2
Biogen
BIIB
$35.3B
$3.67M 4.86%
12,933
+1,105
+9% +$328K
2016 Q2
2 quarters
DTD icon
3
CALL
WisdomTree US Total Dividend Fund
DTD
$1.66B
$3.32M 4.4%
+134,200
New +$5.28M
2016 Q4
0 quarters
CI icon
4
Cigna
CI
$79.1B
$2.48M 3.29%
18,630
+11,512
+162% +$1.51M
2016 Q3
1 quarter
MDCO
5
DELISTED
Medicines Co
MDCO
$2.09M 2.77%
61,554
+25,202
+69% +$894K
2015 Q2
6 quarters
UNH icon
6
UnitedHealth
UNH
$369B
$2.09M 2.77%
13,045
+6,513
+100% +$973K
2016 Q2
2 quarters
BMRN icon
7
BioMarin Pharmaceuticals
BMRN
$11B
$2.03M 2.69%
24,474
+8,839
+57% +$760K
2016 Q2
2 quarters
JAZZ icon
8
Jazz Pharmaceuticals
JAZZ
$13.9B
$2M 2.65%
18,346
-3,045
-14% -$339K
2015 Q1
7 quarters
EW icon
9
Edwards Lifesciences
EW
$49.7B
$1.98M 2.62%
63,423
+4,344
+7% +$141K
2014 Q4
8 quarters
ELV icon
10
Elevance Health
ELV
$93.4B
$1.94M 2.56%
+13,462
New +$1.8M
2016 Q4
0 quarters
RRC icon
11
Range Resources
RRC
$9.63B
$1.82M 2.41%
53,006
+28,235
+114% +$1.01M
2016 Q3
1 quarter
HUM icon
12
Humana
HUM
$52.3B
$1.8M 2.39%
8,828
+2,942
+50% +$561K
2016 Q3
1 quarter
UNP icon
13
Union Pacific
UNP
$171B
$1.74M 2.31%
16,785
-1,233
-7% -$121K
2016 Q3
1 quarter
ZAYO
14
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$1.61M 2.13%
48,877
+19,746
+68% +$646K
2016 Q3
1 quarter
VTRS icon
15
PUT
Viatris
VTRS
$20.8B
$1.53M 2.02%
+40,000
New +$1.49M
2016 Q4
0 quarters
HAIN icon
16
Hain Celestial
HAIN
$25.9M
$1.52M 2.02%
39,072
+22,246
+132% +$833K
2016 Q3
1 quarter
ABBV icon
17
AbbVie
ABBV
$509B
$1.47M 1.95%
23,486
+17,146
+270% +$1.05M
2016 Q1
3 quarters
WBA icon
18
DELISTED
Walgreens Boots Alliance
WBA
$1.34M 1.78%
16,211
-8,688
-35% -$718K
2014 Q4
8 quarters
CRM icon
19
Salesforce
CRM
$202B
$1.33M 1.76%
19,440
+13,249
+214% +$962K
2016 Q3
1 quarter
ALDR
20
DELISTED
Alder Biopharmaceuticals
ALDR
$1.32M 1.75%
63,571
+21,611
+52% +$562K
2014 Q2
10 quarters
ILMN icon
21
CALL
Illumina
ILMN
$40.4B
$1.23M 1.63%
+9,869
New +$1.33M
2016 Q4
0 quarters
AERI
22
DELISTED
Aerie Pharmaceuticals
AERI
$1.21M 1.6%
31,846
-10,592
-25% -$401K
2015 Q1
7 quarters
CLVS
23
DELISTED
Clovis Oncology, Inc.
CLVS
$1.14M 1.51%
25,609
+7,630
+42% +$269K
2013 Q2
14 quarters
SLCA icon
24
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$1.03M 1.36%
18,101
+10,703
+145% +$529K
2016 Q2
2 quarters
DISH
25
DELISTED
DISH Network Corp.
DISH
$884K 1.17%
15,256
-11,902
-44% -$680K
2016 Q2
2 quarters
1
2 3 4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q4 2016 Portfolio in Review

As of Q4 2016, Partner Investment Management held 120 positions worth $75.5M, up 12% from $67.5M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Partner Investment Management withdrew a net $2.58M in Q4 2016, closing 30 positions and reducing 20 holdings. Its most notable exit was Apple, an estimated $1.74M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 49% a quarter earlier, followed by Miscellaneous and Energy.

Against the trend, Partner Investment Management opened a new position in Elevance Health worth $1.94M.

  • Partner Investment Management's largest Q4 2016 buy was Elevance Health: 13,462 shares worth $1.94M.
  • Partner Investment Management added most to Cigna in Q4 2016, an estimated $1.51M increase.
  • Partner Investment Management's biggest Q4 2016 reduction was Voyager Therapeutics, cutting an estimated $1.64M.
  • Partner Investment Management fully exited Apple in Q4 2016, selling an estimated $1.74M.
  • Partner Investment Management's ten largest holdings make up 34% of its $75.5M portfolio in Q4 2016.
  • Partner Investment Management opened 37 new positions and closed 30 in Q4 2016.
  • Partner Investment Management's portfolio value rose 12% quarter-over-quarter to $75.5M.

Based on Partner Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.